Freestone Capital Holdings LLC Trims Stock Position in CVS Health Co. (NYSE:CVS)

Freestone Capital Holdings LLC cut its position in CVS Health Co. (NYSE:CVS) by 25.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 5,086 shares of the pharmacy operator’s stock after selling 1,781 shares during the quarter. Freestone Capital Holdings LLC’s holdings in CVS Health were worth $228,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of CVS. Widmann Financial Services Inc. boosted its stake in CVS Health by 1.8% during the third quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator’s stock valued at $724,000 after buying an additional 200 shares during the period. Manchester Capital Management LLC raised its holdings in shares of CVS Health by 4.8% in the 4th quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator’s stock valued at $200,000 after acquiring an additional 204 shares in the last quarter. Rogco LP boosted its position in shares of CVS Health by 3.2% during the 4th quarter. Rogco LP now owns 6,752 shares of the pharmacy operator’s stock valued at $303,000 after acquiring an additional 210 shares during the last quarter. Lindbrook Capital LLC grew its holdings in shares of CVS Health by 3.8% during the fourth quarter. Lindbrook Capital LLC now owns 6,772 shares of the pharmacy operator’s stock worth $304,000 after purchasing an additional 248 shares in the last quarter. Finally, Glass Jacobson Investment Advisors llc increased its position in shares of CVS Health by 26.8% in the third quarter. Glass Jacobson Investment Advisors llc now owns 1,220 shares of the pharmacy operator’s stock worth $77,000 after purchasing an additional 258 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

Analysts Set New Price Targets

CVS has been the subject of a number of research reports. StockNews.com raised shares of CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday, February 13th. JPMorgan Chase & Co. upped their target price on shares of CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 18th. TD Cowen raised their price target on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. Leerink Partnrs upgraded CVS Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 12th. Finally, Evercore ISI raised their price objective on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday, January 27th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $69.83.

CVS Health Stock Performance

CVS Health stock opened at $66.34 on Friday. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The firm has a market cap of $83.64 billion, a P/E ratio of 18.12, a P/E/G ratio of 0.98 and a beta of 0.54. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The firm has a 50-day moving average of $56.42 and a 200-day moving average of $56.76.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Sell-side analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.01%. CVS Health’s dividend payout ratio is 72.68%.

Insider Activity

In related news, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Michael F. Mahoney acquired 30,000 shares of the firm’s stock in a transaction on Tuesday, February 18th. The stock was purchased at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.24% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.